Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A8CS
|
||||
Former ID |
DNC002518
|
||||
Drug Name |
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551374] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H14N2O2
|
||||
Canonical SMILES |
CCC1=C2C=C(C=CC2=NN1C3=CC=C(C=C3)O)O
|
||||
InChI |
1S/C15H14N2O2/c1-2-15-13-9-12(19)7-8-14(13)16-17(15)10-3-5-11(18)6-4-10/h3-9,18-19H,2H2,1H3
|
||||
InChIKey |
XBMVVMYGKMGLJX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [551374] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.